Smart heart monitor to predict irregular heartbeat early
Part of Heart & circulation clinical trials.
This study is testing an artificial intelligence (AI) tool that uses a simple single-lead ECG (heart rhythm recording) to predict whether a patient will develop atrial fibrillation (a common heart rhythm problem) within the next 2 hours. The goal is to help doctors detect and treat this condition earlier, potentially preventing complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older.
- You must have had a continuous single-lead ECG (heart rhythm) recording taken during a hospital stay at a participating site between September 2022 and September 2025.
- The ECG recording must include at least 10 minutes of usable data, with no more than 5% signal loss or major technical issues.
- If you had a first-time or repeat episode of atrial fibrillation (irregular heartbeat), the recording must cover 2 hours before and 1 hour after the episode.
- You cannot be pregnant or breastfeeding at the time of the recording, and your data must not have been used in previous AI model training.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.
This trial uses an artificial intelligence tool to read your heart's electrical signals and check how well your heart is recovering after a procedure to fix an irregular heartbeat called atrial fibrillation. It aims to find early signs of heart failure and guide better care.
This study uses an artificial intelligence (AI) tool to read your heart's electrical activity (ECG) to help doctors better manage your atrial fibrillation (AFib), an irregular heartbeat that can increase stroke risk. By combining the ECG with a heart ultrasound (echocardiogram), the AI aims to improve treatment decisions and outcomes.
This study looks at heart monitoring data to see if a new method can predict when atrial fibrillation might cause a rapid heart rate within the next 2 hours. If you have had atrial fibrillation and heart monitoring in the hospital, your data might help this research.
This trial tests if smartphones and their accessories can detect a specific type of irregular heart rhythm called atrial fibrillation. If you have a form of atrial fibrillation or a normal heart rhythm, you may help see how well these devices work.
Hear when a new Atrial Fibrillation New Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.